Egis Atorvastatin - Dapagliflozin Egis Atorvastatin - Dapagliflozin

X

List of Suppliers' Granulation Excipients Application used in MolPort-000-883-773 on PharmaCompass.com

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
205
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

JP

Other Listed Suppliers

SERVICES
URL Supplier Web Content
LM Application #LearnMore
Dosage Form: Tablet
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
LM Application #LearnMore
Dosage Form: Tablet
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
LM Application #LearnMore
Dosage Form: Tablet
Route of Administration (Grade): Oral
Pharmacopoeia Reference: USP/NF, Ph. Eur., Ch. P.
Technical Specifications: NA
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
LM Application #LearnMore
Ingredient(s): Lactose Monohydrate
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to USP-NF, Ph.Eur., JP lactose monohydrate monograph
Technical Specifications: Density- Tapped density- 857 g/l, Bulk density- 589 g/l; Particle size- D10- 5 ?m, D50- 40 ?m, D90- 120 ?m; Hausner ratio- 1,46
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
LM Application #LearnMore
Ingredient(s): Sodium Lauryl Sulfate
Dosage Form: Tablet
Category: Granulation
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Sodium Laurilsulfate; USP-NF, JP: Sodium Lauryl Sulfate
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
LM Application #LearnMore
Ingredient(s): Sodium Lauryl Sulfate
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Sodium Laurilsulfate; USP-NF, JP: Sodium Lauryl Sulfate
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
LM Application #LearnMore
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
LM Application #LearnMore
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
LM Application #LearnMore
Dosage Form: Tablet
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Monograph- USP/NF, JP/JPE
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
LM Application #LearnMore
Ingredient(s): Lactose Monohydrate
Dosage Form: Tablet
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Monograph- USP/NF, JP/JPE
Technical Specifications: Milled; Also Available as Microlex® LCM 180.m, Microlex® LCM 200.m
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
LM Application #LearnMore
Ingredient(s): Lactose Monohydrate
Dosage Form: Tablet
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Monograph- USP/NF, JP/JPE
Technical Specifications: Sieved; Also Available as Microlex® LCM 180.s, Microlex® LCM 220.s
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
LM Application #LearnMore
Ingredient(s): Anhydrous Lactose
Dosage Form: Tablet
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Monograph- USP/NF, JP/JPE
Technical Specifications: Milled; Also Available as Microlex® LCA 120.m, Microlex® LCA 200.m
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
LM Application #LearnMore
Ingredient(s): Mannitol
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Topical, Oral
Pharmacopoeia Reference: Monograph- Ph.Eur, USP/NF
Technical Specifications: Available in different particle size as 25.µ, 50.µ, 180.µ
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
LM Application #LearnMore
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP monograph "Copovidone" and the JPE monograph "Copolyvidone"
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
LM Application #LearnMore
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP monograph "Copovidone" and the JPE monograph "Copolyvidone"
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ingredient(s): polyethylene glycol
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Polyvinyl caprolactam – polyvinyl acetate – polyethylene glycol graft copolymer
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
LM Application #LearnMore
Ingredient(s): Crospovidone
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: 90 % mannitol, 5 % crospovidone, 5 % polyvinyl acetate
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
left grey arrow
right gray arrow
  • TABLET;ORAL - EQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • TABLET;ORAL - EQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • TABLET;ORAL - EQ 40MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • TABLET;ORAL - EQ 80MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • TABLET;ORAL - EQ 10MG BASE
  • TABLET;ORAL - EQ 20MG BASE
  • TABLET;ORAL - EQ 40MG BASE
  • TABLET;ORAL - EQ 80MG BASE
  • TABLET;ORAL - EQ 10MG BASE;EQ 10MG BASE
  • TABLET;ORAL - EQ 10MG BASE;EQ 20MG BASE
  • TABLET;ORAL - EQ 10MG BASE;EQ 40MG BASE
  • TABLET;ORAL - EQ 10MG BASE;EQ 80MG BASE
  • TABLET;ORAL - EQ 2.5MG BASE;EQ 10MG BASE
  • TABLET;ORAL - EQ 2.5MG BASE;EQ 20MG BASE
  • TABLET;ORAL - EQ 2.5MG BASE;EQ 40MG BASE
  • TABLET;ORAL - EQ 5MG BASE;EQ 10MG BASE
  • TABLET;ORAL - EQ 5MG BASE;EQ 20MG BASE
  • TABLET;ORAL - EQ 5MG BASE;EQ 40MG BASE
  • TABLET;ORAL - EQ 5MG BASE;EQ 80MG BASE
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY